Use of a second-generation CA125 assay in gynecologic patients

Gynecologic and Obstetric Investigation

Volumn 42, Issue 3, 1996, Pages 196-200

  Homstein, Mark D ^a   Goodman, Howard M ^a   Thomas, Phaedra P ^a   Knapp, Robert C ^a   Harlow, Bernard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

CA125; CA125 II

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGE; ARTICLE; CIGARETTE SMOKING; ETHNOLOGY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUATION; OVARY CYST; PRIORITY JOURNAL;

EID: 0029808016     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000291954     Document Type: Article

References (23)

1. Bast RC Jr. Freeney M. Lazarus H. Nadler LM. Colvin RB, Knapp RC: Reactivity of a monoclonal antibody with human ovarian carcinoma. J Clin Invest 1981:68:1331 -1337.
2. Kabawat SE. Bast RC Jr. Welch WR. Knapp RC, Colvin RB: Immunopathologic characterization of a monoclonal antibody that recognizes common surface antigens in human ovarian tumors of serous, endometrioid, and clear cell types. Am J Clin Pathol 1983:79:98-104.
3. Kabawat SE. Bast RC Jr. Bhan AK. Welch WR. Knapp RC, Colvin RB: Tissue distribution of a coclomic epithelium-related antigen recognized by the monoclonal antibody OC-125. Int J Gynecol Pathol 1983:2:275-285.
4. Matsuho Y. Zalutskv M. Knapp RC. Bast RC Jr.: Interaction of monoclonal antibodies with cell surface antigens of human ovarian carcinoma. Cancer Res 1984:44:2813-2819.
5. Bast RC Jr. Klug TC, St John E, Jenison E, Nilof TJM, Lazarus H, Bcrkowitz RS. Leavitt T. Griffiths CT, Parker L. Zurawski VR Jr. Knapp RC: A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. N Engl J Med 1983; 309:883-887.
6. Barbieri RL. Niloff JM. Bast RC Jr. Schaetzl E, Kistner RW. Knapp RC: Elevated serum concentration of CA125 in patients with advanced endometriosis. Fertil Steril 1986:45:630-634.
7. Patton PE, Field CS, Harms RW, Coulam CB: CA125 levels in endometriosis. Fertil Steril 1986:45:770-773.
8. Giudice LC, Jacobs A. Pineda J, Bell CE, Lipp-man L: Serum levels of CA 125 in patients with endometriosis: A preliminary report. Fertil Steril 1986;45:876-878.
9. Pittaway DE, Faycz JA: The use of CAI25 in the diagnosis and management of endometriosis. Fertil Steril 1986:46:790-795.
10. Kauppila A. Tclimaa S. Ronnbcrg L. Vuori J: Placebo-controlled study on scrum concentrations of CAI25 before and after treatment of endometriosis with danazol or high-dosc medroxyprogesterone acetate alone or after surgery.,'Fertil Steril 1988:49:37-41.
11. Moretuzzo RW, DiLauro S. Jenison E. Chen SL, Reindollar RH, McDonough PG: Serum and peritoneal lavage fluid CAI25 levels in endometriosis. Fertil Steril 1988,50:430-433.
12. Fedele L. Arcaini L, Vcrccllim P, Bianchi S, Canadiani GB: Serum CAI25 measurements in the diagnosis of endometriosis recurrence. Obstet Gynecol 1988;72:19-22.
13. Fedele L. Vercellini P. Arcaini L. daDalt MG. Canadiani GB: CA125 in scrum, peritoneal fluid, active lesions, and endometrium of patients with endometriosis. Am J Obstet Gynecol 1988;158:166-170.
14. Dawood MY, Khan-Dawood FS, Ramnos J: Plasma and peritoneal fluid levels of CA 125 in women with endometriosis. Am J Obstct Gynecol 1988;159:1526-1531.
15. Lanzone A, Marana R. Muscatello R. Fulghesu AM, Dell’Acqua S, Caruso A, Mancuso S: Serum CAI25 levels in the diagnosis and management of endometriosis. J Rcprod Med 1991;36: 603-607.
16. Hornstein MD. Thomas PP. Gleason RE. Barbieri RL: Menstrual cyclicity of CAI25 in patients with endometriosis. Fertil Steril 1992:58: 279-283.
17. Nilol TJM, Knapp RC, Schaetzl E. Reynolds C. Bast RC Jr.: CAI25 antigen levels in obstetric and gynecologic patients. Obstet Gynecol 1984;64:703-707.
18. Harcardottir H. Parmlcy TH Jr. Quirk JG Jr. Sanders MM. Miller FC, O'Brien TJ. Parmley TH: Distribution of CA125 in embryonic tissues and adult derivatives of the fetal periderm. Am J Obstet Gynecol 1990:163:1925-1931.
19. O'Brien TH. Raymond LM. Bannon GA. Ford DH, Hardardottir H. Miller FC, Quirk JG Jr.: New monoclonal antibodies identify the glycoprotein carrying the CA125 epitope. Am J Obstct Gynecol 1991:165:1857-1866.
20. Kenemans P. Van Kemp GJ. Oehr P. Ver-straetcn RA: Heterologous double-determinant immunoradiometric assay CA125 II: Reliable second-generation immunoassay for determining CA125 in scrum. Clin Client 1993:39: 2509-2514.
21. Muto MG. Cramer DW. Brown DL. Welch WR, Harlow BL, Xu H. Bracks JP, Tsao SW, Berkawitz RS: Screening for ovarian cancer: The preliminary experience of a familial ovarian cancer center. Gvnecol Oncol 1993:51:12-20.
22. Alagoz T. Buller RE, Berman M, Anderson B. Manetta A. DiSaia P: What is a normal CA125 level? Gynecol Oncol 1994:53:93-97.
23. Clement M, Bischof P, Groffat C, Ricollcau G, Auvray E, Quillien V, Pacheco C, Torres M. Ferdeghini M: Clinical validation of the new ELSA-CA125 II assay: Report of a European multicenter evaluation. Int J Cancer 1995:60: 199-203.